18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) as early imaging biomarker of axillary sentinel lymph node (SLN) status in locally advanced node-positive breast cancer (NPBC) patients (pts) receiving neoadjuvant chemotherapy (NACT)
Dockx, Yanina, Huizing, Manon Thirza, Van Den Wyngaert, Tim, Altintas, Sevilay, Huyghe, Ivan, Geboers, Inge, Vervliet, Johan, Molderez, Christoph, van Goethem, Mireille, van Marck, Veerle, Sonnemans, Hetty, Tjalma, Wiebren
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article